National Research Corp. engages in the provision of analytics and insights that facilitate patient, employee, and customer retention. The company is headquartered in Lincoln, Nebraska and currently employs 368 full-time employees. Its digital solutions consist of four solution categories: Patient Experience, Consumer Experience, Employee Experience, and Market Experience, which can be implemented both collectively as an enterprise solution or individually to meet specific needs within the organization. Its Marketing solutions are subscription-based services that allow for improved tracking of awareness, perception, and consistency of healthcare brands; real-time assessment of competitive differentiators, and enhanced segmentation tools. Its Reputation solutions allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs better consumer decision-making.
Based on comprehensive analyst evaluations, we have synthesized critical insights from expert assessments to outline a cautious outlook for NRC. Analysts note deteriorating fundamentals and challenging market sentiment, indicating potential downside risks in the near term. Following this expert analysis, we adopt a bearish stance on this stock. Our conclusion: NRC is a Sell candidate.
NRC stock price ended at $13.77 on 水曜日, after dropping 5.43%
On the latest trading day Feb 11, 2026, the stock price of NRC fell by 5.43%, dropping from $14.51 to $13.77. During the session, the stock saw a volatility of 14.02%, with prices oscillating between a daily low of $13.12 and a high of $14.96. On the latest trading day, the trading volume for NRC decreased by 149.1K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 69.3K shares were traded, with a market value of approximately $312.0M.